Page 59 - XXIV Monografías en Esclerosis Múltiple

PATOGENIA DE LA ESCLEROSIS MÚLTIPLE
02
21. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130(4):1089-104.
22. Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, et al. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol. 2010 Apr;67(4):452-61.
23. Lovato L, Willis SN, Rodig SJ, Caron T, Almendinger SE, Howell OW, et al. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain. 2011 Feb;134(2):534-41.
24. Corsiero E, Bombardieri M, Manzo A, Bugatti S, Uguccioni M, Pitzalis C. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoim- mune diseases. Immunol Lett. 2012;145(1-2):62-7.
25. von Büdingen H-C, Harrer MD, Kuenzle S, Meier M, Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur J Immunol. 2008 Jul;38(7):2014-23.
26. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain. 1994;117(4):759-65.
27. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Corti- cal demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005 Nov;128(Pt 11):2705-12.
28. Ascherio A, Munger KL, Lünemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol. 2012 Oct 9;8(11):602-12.
29. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008 Sep;7(9):852-8.
30. Hassani A, Corboy JR, Al-Salam S, Khan G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One. 2018;13(2):e0192109. 31. Hislop AD. Early virological and immunological events in Epstein-Barr virus infection. Curr Opin
Virol. 2015 Dec;15:75-9.
32. Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R. Cortical grey matter
demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of
MOG-immunized rats. Brain. 2013 Dec;136(Pt 12):3596-608.
33. Venters HD, Dantzer R, Kelley KW. A new concept in neurodegeneration: TNFα is a silencer of
survival signals. Trends Neurosci. 2000 Apr;23(4):175-80.
34. Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y, et al. Interferon- directly
induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN- receptor and
AMPA GluR1 receptor. FASEB J. 2008;22(6):1797-806.
35. Metz I, Weigand S, Popescu B, Frischer J, Parisi J, Guo Y, et al. Pathologic heterogeneity persists in
early active multiple sclerosis lesions. Ann Neurol. 2014;75(5):728-38.
36. Correale J, Farez MF. The Role of Astrocytes in Multiple Sclerosis Progression. Front Neurol. 2015
Aug 18;6.
37. Mayo L, Trauger S, Blain M, Nadeau M, Patel B, Alvarez J, et al. Regulation of astrocyte activation
by glycolipids drives chronic CNS inflammation. Nat Med. 2014;20(10):1147-56.
38. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal Transection in the Lesions
of Multiple Sclerosis. N Engl J Med. 1998 Jan 29;338(5):278-85.
39. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev
Neurosci. 2008;31:247-69.
59